Observational studyBMC oral health2026
Defect morphology dictates success: suprabony lesions outperform intrabony defects in non-surgical periodontal therapy: a 3-month prospective observational study.
Observational study in BMC oral health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aimed to compare the clinical response of suprabony and intrabony defects to non-surgical periodontal therapy (NSPT) and evaluate the influence of defect morphology on treatment outcomes.
methodsA prospective observational study with a 3-month follow-up was conducted on 413 patients who underwent NSPT at a tertiary hospital. Periapical radiographs and clinical parameters, including probing pocket depth (PPD), bleeding on probing (BoP), and clinical attachment level (CAL), were assessed at baseline and 3-month follow-up. Defects were classified as suprabony or intrabony based on radiographic morphology. Multilevel modeling was used to analyze the contributions of site-, tooth-, patient-, and treatment-related factors to clinical outcomes, with pocket closure (PPD ≤ 4 mm without BoP) as the primary endpoint.
resultsIntrabony defects exhibited greater absolute PPD reduction (0.9 ± 2.4 mm) compared to suprabony defects (0.7 ± 1.8 mm), a difference attributable to their deeper baseline PPD (6.1 ± 2.4 mm vs. 4.2 ± 2.0 mm). Multilevel modeling, after adjusting for baseline severity, demonstrated that defect morphology was the strongest predictor of therapeutic success. Suprabony defects achieved a greater adjusted PPD reduction and CAL gain (by 0.6 mm each) compared to intrabony defects. Suprabony defects demonstrated superior pocket closure rates and were 2.4 times more likely to achieve closure than intrabony defects. Site-related factors accounted for 64.9% of outcome variability, followed by patient- (26.1%), tooth- (9.0%), and treatment-related factors (1%). Multilevel analysis confirmed defect morphology as the strongest predictor of success, with suprabony defects showing 0.6 mm greater PPD reduction and CAL gain.
conclusionDefect morphology significantly influences NSPT outcomes, with suprabony defects exhibiting higher pocket closure rates and better clinical improvements than intrabony defects. These findings highlight the need for morphology-adapted treatment strategies in periodontal therapy. However, the interpretation of these results should be cautious due to the relatively short 3-month follow-up period, which may not fully reflect long-term treatment stability and periodontal remodeling.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.